Beam Therapeutics Inc. Income Taxes Paid, Net
Beam Therapeutics Inc. (BEAM) reported Income Taxes Paid, Net of $159.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2021-05-11
- Beam Therapeutics Inc. income taxes paid, net for the quarter ending 2021-03-31 was $159.00K, a 18.66% increase year-over-year.
- Beam Therapeutics Inc. income taxes paid, net for the quarter ending 2020-12-31 was $139.00K, a 16.81% increase year-over-year.
- Beam Therapeutics Inc. income taxes paid, net for the quarter ending 2020-09-30 was $140.00K.
- Beam Therapeutics Inc. income taxes paid, net for the quarter ending 2020-06-30 was $148.00K.
- Beam Therapeutics Inc. income taxes paid, net for fiscal 2020 was $561.00K, a 200.00% increase from fiscal 2019.
- Beam Therapeutics Inc. income taxes paid, net for fiscal 2019 was $187.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2021-03-31 | $159.00K 10-Q · filed 2021-05-11 | $298.00K derived: sum of 2 quarters · filed 2021-05-11 | $438.00K derived: sum of 3 quarters · filed 2021-05-11 | $586.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $279.00K derived: sum of 2 quarters · filed 2021-03-15 | $427.00K derived: sum of 3 quarters · filed 2021-03-15 | $561.00K 10-K · filed 2021-03-15 |
| 2020-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $288.00K derived: sum of 2 quarters · filed 2020-11-10 | $422.00K 10-Q · filed 2020-11-10 | $541.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-06-30 | $148.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $282.00K 10-Q · filed 2020-08-12 | $401.00K derived: sum of 3 quarters · filed 2021-05-11 | |
| 2020-03-31 | $134.00K 10-Q · filed 2021-05-11 | $253.00K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $187.00K 10-K · filed 2021-03-15 | ||
| 2019-09-30 | $68.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |